Posted on 1/12/21
Privitar Appoints Lars Björk to Its Board of Directors
Privitar, the leading data privacy platform provider, today announced the appointment of Lars Björk, former CEO of Qlik, to its Board of Directors.
Posted on 1/11/21
Beam Therapeutics Appoints Kate Walsh to its Board of Directors
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Kate Walsh,
Posted on 1/11/21
Louis Pascarella Appointed Chief Executive Officer of Innocoll
Innocoll Holdings Limited, a specialty pharmaceutical company wholly owned by Gurnet Point Capital, a private investment firm focused on health care, today announced that Louis Pascarella
Posted on 1/7/21
IPG Photonics Corp. Appoints Jeanmarie Desmond and Natalia Pavlova to its Board
IPG Photonics Corporation (NASDAQ: IPGP) today announced that the Company has appointed Ms. Jeanmarie Desmond and Ms. Natalia Pavlova to its board of directors, effective January . . .
Posted on 1/7/21
Smurfit Kappa Group CEO Tony Smurfit Named 2021 European CEO of the Year
Fastmarkets RISI, the definitive source of commodity data and insights for the forest products industry, today has announced that Tony Smurfit, CEO of Smurfit Kappa Group, . . .
Posted on 1/7/21
Senda Biosciences Formation of World-Class Scientific Advisory Board
Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board
Posted on 1/7/21
TScan Therapeutics Appoints Brian M. Silver, J.D., to Board
WALTHAM, Mass.--(BUSINESS WIRE)--TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology, today announced the appointment of Brian . . .
Posted on 1/7/21
LifeMine Therapeutics Appoints Nobel Laureate William G. Kaelin Jr., M.D., to Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc, a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced the appointment . . .
Posted on 1/7/21
Forma Therapeutics Appoints Selwyn M. Vickers, M.D., to Board
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that Selwyn M. Vickers, M.D., F.A.C.S., has . . .
Posted on 1/6/21
Boston Digital Promotes Peter Prodromou to CEO
Boston Digital today announced changes at the executive level with founder Chuck Murphy stepping into the role of Chairman of the Board, and naming current President, . . .
Posted on 1/6/21
Brainwave Science Announces its Scientific Advisory Board
Brainwave Science today announced its Scientific Advisory Board, which includes such well known industry figures as Dr. Peter Rosenfeld, Dr. Laxmidhar Bedera
Posted on 1/6/21
Entrada Therapeutics Appoints Dr. Peter Kim to Board
Entrada Therapeutics, a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced the appointment of Peter S. Kim, Ph.D
Posted on 1/6/21
Jnana Therapeutics Appoints Dr. Annie Chen to Board of Directors and Dr. Katalin Susztak to Scientific Advisory Board
BOSTON--(BUSINESS WIRE)--Jnana Therapeutics, a biotechnology company targeting the solute carrier (SLC) family of metabolite transporters to treat underserved diseases, today announced the appointment of two experienced . . .
Posted on 1/6/21
Dr. Joachim Hasenmaier Joins Invetx Board of Directors
Invetx, a pioneer in protein-based therapeutics for animal health, announced today that Dr. Joachim Hasenmaier has joined the company’s board of directors.
Posted on 1/6/21
Gutenberg Technology Appoints Dr. Adam Black to Advisory Board
BOSTON--(BUSINESS WIRE)--Gutenberg Technology (GT), provider of the premier end-to-end content management platform, today announced the appointment of Dr. Adam Black to its advisory board, effective immediately. . . .
Posted on 1/6/21
Alegeus Appoints Leif O’Leary as Chief Executive Officer
Alegeus, the market leader in consumer-directed healthcare (CDH) solutions, has welcomed three new members to its executive leadership team over the past several months: Leif O’Leary
Posted on 1/5/21
Newman's Own Appoints Michael Mardy to Board of Directors
Newman's Own, Inc., the food and beverage company that was created by Paul Newman to give 100% of its profits to charity, announced the appointment of . . .
Posted on 1/5/21
Inari Appoints Bob Bechek to Board
Inari, a biotech seed company, today announced that Bob Bechek has been appointed to its board of directors.
Posted on 1/5/21
Exicure Appoints James Sulat to Board
Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid technology, today announced the appointment of James Sulat to its . . .
Posted on 1/5/21
Aura Biosciences Appoints David Johnson to Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a clinical-stage oncology company developing a novel class of drug conjugate therapies for multiple oncology indications, today announced the appointment of David . . .
Posted on 1/5/21
Apic Bio Appoints Stephen Hoffman, MD, PhD, as Board Chair
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apic Bio Inc. today announced the appointment of Stephen Hoffman, MD, PhD, as Chairman of the Board. Dr. Hoffman has a distinguished career in . . .
Posted on 1/5/21
Radius Health Appoints Machelle Sanders and Andrew von to Board of Directors
Radius Health, Inc. (Nasdaq: RDUS) announced today that Machelle Sanders and Dr. Andrew C. von Eschenbach have joined the Company’s board of directors.
Posted on 1/4/21
Enzo Pharmaceuticals Appoint Richard L. Feinstein as CEO
Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire
Posted on 1/3/21
Cognoptix Announces Formation of a New Board of Directors
Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer's disease (AD).
Posted on 1/3/21
Tronox Appoints John D. Romano and Jean-François Turgeon co-Chief Executive Officers on Interim Basis
Tronox Holdings plc (NYSE:TROX), the world's leading integrated manufacturer of titanium dioxide pigment, today announced that its Board of Directors appointed John D. Romano, Executive Vice . . .
Boston
